Can Erythrocyte Catalase Regulate Blood Pressure?

Area of Science:

• Cardiovascular Medicine
• Pharmacology
• Biochemistry

Background:

• Hypertension is a major risk factor for cardiovascular diseases.
• Understanding the mechanisms of blood pressure control is crucial for effective antihypertensive therapy.
• The role of erythrocyte catalase in blood pressure regulation remains largely unexplored.

Purpose of the Study:

• To investigate the impact of lisinopril, an antihypertensive drug, on plasma lipid profiles and erythrocyte catalase activity in hypertensive patients.
• To explore the relationship between blood pressure levels and erythrocyte catalase activity.
• To determine if lisinopril therapy affects lipid and cholesterol metabolism.

Main Methods:

• A cohort of hypertensive patients received lisinopril treatment.
• Plasma cholesterol (total and LDL) and triglyceride levels were measured at baseline and at 1, 3, and 6 months.
• Erythrocyte catalase activity and blood pressure (systolic and diastolic) were assessed concurrently.

Main Results:

• Lisinopril significantly reduced both systolic and diastolic blood pressure.
• Significant inverse correlations were observed between systolic blood pressure and erythrocyte catalase activity, and between diastolic blood pressure and erythrocyte catalase activity.
• Plasma total cholesterol, LDL cholesterol, and triglyceride levels showed no significant changes during lisinopril treatment.

Conclusions:

• Lisinopril effectively lowers blood pressure in hypertensive individuals.
• Erythrocyte catalase activity is inversely associated with blood pressure, suggesting a potential role in blood pressure regulation.
• Antihypertensive therapy with lisinopril does not appear to influence lipid-cholesterol metabolism.